Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Adult-onset vitelliform macular dystrophy

Other Names for this Disease
  • Adult-onset foveomacular vitelliform dystrophy
  • AVMD
  • Foveomacular dystrophy, adult-onset, with choroidal neovascularization
  • Foveomacular dystrophy, adult-onset; AOFMD
  • Macular dystrophy, vitelliform, adult-onset
More Names
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


Newline Maker

How might adult-onset vitelliform macular dystrophy be treated?

Management for this condition should include a comprehensive eye examination, including dilation, once or twice a year to rule out any possible complications. If vision is impaired, patients should be referred for low vision testing and rehabilitation. Intravitreal injections of either Ranibizumab or Bevacizumab may be effective in the short-term.[1] Transcorneal electrical stimulation has also been found to improve visual acuity in individuals with this condition.[2]
Last updated: 3/31/2014

  1. Chan, S and Macdonald I. Adult-onset foveomacular vitelliform dystrophy. Orphanet. December 2013; Accessed 3/31/2014.
  2. Ozeki N, Shinoda K, Ohde H et al. Improvement of visual acuity after transcorneal electrical stimulation in case of Best vitelliform macular dystrophy.. Graefes Arch Clin Exp Ophthalmol. April 19, 2013; 251(7):1867-70. Accessed 3/31/2014.

Clinical Trials & Research for this Disease

  • Orphanet lists clinical trials, research studies, and patient registries enrolling people with this condition. Click on Orphanet to view the list.